[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-001", "question": "A 4-year-old boy presents with recurrent bacterial infections since infancy, including pneumonia and otitis media. Laboratory evaluation reveals absent CD19+ B cells, normal T cell numbers with preserved proliferation to mitogens, and undetectable serum immunoglobulins. Genetic testing identifies a mutation in a cytoplasmic tyrosine kinase essential for B cell development. His 2-year-old brother is asymptomatic but has the same mutation. Which of the following best explains the brother's lack of clinical manifestations?", "options": ["Residual maternal IgG providing passive immunity", "Somatic mosaicism with partial gene function restoration", "Compensatory upregulation of alternative signaling pathways", "X-chromosome inactivation favoring the wild-type allele", "Presence of a hypomorphic rather than null mutation"], "answer": "A", "answer_index": 0, "explanation": "This case describes X-linked agammaglobulinemia (XLA) due to BTK mutation. At age 2, the asymptomatic brother may still have residual transplacentally acquired maternal IgG, which typically wanes by 6-9 months but can persist longer in some cases, providing temporary protection. X-chromosome inactivation is irrelevant as this is an X-linked recessive condition affecting males who have only one X chromosome. Somatic mosaicism and hypomorphic mutations would show some B cell development, which is absent here.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (No answer defensible)\\nVerdict on keyed answer: No defensible answer\\n\\nThe item describes X-linked Agammaglobulinemia (XLA) caused by a BTK mutation. The question asks why a 2-year-old brother with the same mutation is asymptomatic. The keyed answer (A) claims this is due to residual maternal IgG. This is medically incorrect and physiologically impossible. Transplacentally acquired maternal IgG has a half-life of ~3-4 weeks and is catabolized to negligible levels by 6-9 months of age (the physiologic nadir). It does not persist to provide protection at 2 years of age. \\n\\nRegarding the distractors: Option D is impossible because males (XY) do not undergo X-chromosome inactivation. Options B, C, and E are inconsistent with the premise that the brother has the 'same mutation' as the severe index case (implying a germline null mutation) or are not standard mechanisms for XLA. Since the intended key relies on a false medical premise and no other option is viable, the question is unsolvable.\\n\\nMinimal fix: Change the brother's age to '3 months' or '4 months'. At that age, maternal IgG would still be present and protective, making Option A correct.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (No answer defensible)\nVerdict on keyed answer: No defensible answer\n\nThe item describes X-linked Agammaglobulinemia (XLA) caused by a BTK mutation. The question asks why a 2-year-old brother with the same mutation is asymptomatic. The keyed answer (A) claims this is due to residual maternal IgG. This is medically incorrect and physiologically impossible. Transplacentally acquired maternal IgG has a half-life of ~3-4 weeks and is catabolized to negligible levels by 6-9 months of age (the physiologic nadir). It does not persist to provide protection at 2 years of age. \n\nRegarding the distractors: Option D is impossible because males (XY) do not undergo X-chromosome inactivation. Options B, C, and E are inconsistent with the premise that the brother has the 'same mutation' as the severe index case (implying a germline null mutation) or are not standard mechanisms for XLA. Since the intended key relies on a false medical premise and no other option is viable, the question is unsolvable.\n\nMinimal fix: Change the brother's age to '3 months' or '4 months'. At that age, maternal IgG would still be present and protective, making Option A correct.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-002", "question": "A 58-year-old woman with metastatic melanoma receiving combination ipilimumab and nivolumab develops acute onset confusion, fever to 39.2°C, and neck stiffness on day 21 of treatment. CSF analysis shows 180 WBC/μL (92% lymphocytes), protein 156 mg/dL, glucose 52 mg/dL (serum 98 mg/dL), and negative Gram stain. MRI brain shows leptomeningeal enhancement. CSF cytology and flow cytometry are negative for malignant cells. Which additional CSF finding would most strongly support the diagnosis of immune checkpoint inhibitor-induced aseptic meningitis over infectious or neoplastic etiologies?", "options": ["Elevated CSF adenosine deaminase level", "Presence of oligoclonal bands with matched serum bands", "Markedly elevated CSF IL-17 levels", "CD4+/CD8+ T cell ratio greater than 4:1 with activated phenotype", "Elevated CSF beta-2 microglobulin"], "answer": "D", "answer_index": 3, "explanation": "Immune checkpoint inhibitor-induced aseptic meningitis characteristically shows a CD4+ predominant lymphocytic pleocytosis with activated T cell phenotype (expressing HLA-DR, CD69), reflecting the mechanism of enhanced T cell activation. Elevated ADA suggests tuberculosis; oligoclonal bands suggest MS or infectious processes; elevated IL-17 is nonspecific; beta-2 microglobulin elevation occurs in lymphomatous meningitis. The CD4+/CD8+ ratio with activation markers specifically reflects the immunologic mechanism of checkpoint inhibitor toxicity.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a patient with suspected immune checkpoint inhibitor (ICI)-induced aseptic meningitis and asks for a supportive CSF finding. The keyed answer (D) claims a CD4+/CD8+ ratio > 4:1 is characteristic. This is medically inaccurate and problematic for two reasons: 1) In board examinations and clinical practice, a CSF CD4/CD8 ratio > 4:1 (often > 5:1) is the specific hallmark of Neurosarcoidosis. 2) ICI-induced meningitis is a diagnosis of exclusion; while it involves T-cell activation, literature reports variable immunophenotypes (often CD8+ predominant or mixed), and there is no consensus on a diagnostic ratio > 4:1. Options A (ADA) and E (Beta-2 microglobulin) correctly point to TB and Lymphoma, respectively, which the question asks to exclude. While D is the intended answer by elimination (linking T-cell activation to the drug mechanism), it relies on a specific finding that strongly points to a different diagnosis (Sarcoidosis) rather than the one in the stem. Thus, the item relies on a false premise.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a patient with suspected immune checkpoint inhibitor (ICI)-induced aseptic meningitis and asks for a supportive CSF finding. The keyed answer (D) claims a CD4+/CD8+ ratio > 4:1 is characteristic. This is medically inaccurate and problematic for two reasons: 1) In board examinations and clinical practice, a CSF CD4/CD8 ratio > 4:1 (often > 5:1) is the specific hallmark of Neurosarcoidosis. 2) ICI-induced meningitis is a diagnosis of exclusion; while it involves T-cell activation, literature reports variable immunophenotypes (often CD8+ predominant or mixed), and there is no consensus on a diagnostic ratio > 4:1. Options A (ADA) and E (Beta-2 microglobulin) correctly point to TB and Lymphoma, respectively, which the question asks to exclude. While D is the intended answer by elimination (linking T-cell activation to the drug mechanism), it relies on a specific finding that strongly points to a different diagnosis (Sarcoidosis) rather than the one in the stem. Thus, the item relies on a false premise.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-003", "question": "A 6-month-old infant presents with progressive hypotonia, poor feeding, and developmental regression over 2 weeks. Parents report a recent upper respiratory infection. Examination reveals absent deep tendon reflexes, tongue fasciculations, and paradoxical breathing. EMG shows fibrillation potentials and reduced motor unit recruitment. Genetic testing for SMN1 deletions is negative. CSF protein is markedly elevated at 280 mg/dL. Which of the following is the most likely diagnosis?", "options": ["Infantile-onset Pompe disease", "Acute motor axonal neuropathy variant of Guillain-Barré syndrome", "Spinal muscular atrophy type 1 with atypical genetics", "Infantile botulism", "Cytomegalovirus-associated polyradiculopathy"], "answer": "B", "answer_index": 1, "explanation": "The combination of acute/subacute onset following infection, areflexia, tongue fasciculations (cranial nerve involvement), paradoxical breathing, EMG showing denervation, and markedly elevated CSF protein with albuminocytologic dissociation strongly suggests acute motor axonal neuropathy (AMAN), a GBS variant. SMA type 1 would have positive SMN1 testing in >95% of cases and insidious onset. Infantile botulism shows decremental response on repetitive stimulation and normal CSF. Pompe disease shows myopathic EMG changes. CMV polyradiculopathy typically occurs in immunocompromised patients.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item presents a diagnostic challenge requiring the candidate to weigh conflicting clinical and laboratory data. The clinical presentation includes 'tongue fasciculations,' a classic board buzzword for Spinal Muscular Atrophy (SMA). However, the objective data definitively rules out SMA: the SMN1 deletion test is negative (excluding 95% of SMA cases), and the CSF protein is markedly elevated (280 mg/dL), which is inconsistent with SMA (typically normal CSF) but characteristic of Guillain-Barré Syndrome (GBS). The history of a recent URI, acute progression, and areflexia supports GBS. Specifically, the Acute Motor Axonal Neuropathy (AMAN) variant fits the EMG findings of fibrillation potentials (denervation) and reduced recruitment. While tongue fasciculations are an atypical description for GBS (cranial nerve involvement usually presents as weakness/palsy rather than fasciculations, which imply anterior horn cell pathology), the high CSF protein and negative genetics make Option B the only medically defensible choice among the options. Options A, D, and E are excluded by the EMG pattern, CSF findings, and clinical context. The item is logically valid as a 'best answer' question where objective data overrides a specific physical exam distractor.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item presents a diagnostic challenge requiring the candidate to weigh conflicting clinical and laboratory data. The clinical presentation includes 'tongue fasciculations,' a classic board buzzword for Spinal Muscular Atrophy (SMA). However, the objective data definitively rules out SMA: the SMN1 deletion test is negative (excluding 95% of SMA cases), and the CSF protein is markedly elevated (280 mg/dL), which is inconsistent with SMA (typically normal CSF) but characteristic of Guillain-Barré Syndrome (GBS). The history of a recent URI, acute progression, and areflexia supports GBS. Specifically, the Acute Motor Axonal Neuropathy (AMAN) variant fits the EMG findings of fibrillation potentials (denervation) and reduced recruitment. While tongue fasciculations are an atypical description for GBS (cranial nerve involvement usually presents as weakness/palsy rather than fasciculations, which imply anterior horn cell pathology), the high CSF protein and negative genetics make Option B the only medically defensible choice among the options. Options A, D, and E are excluded by the EMG pattern, CSF findings, and clinical context. The item is logically valid as a 'best answer' question where objective data overrides a specific physical exam distractor.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-004", "question": "A 45-year-old man with acute myeloid leukemia undergoes allogeneic hematopoietic stem cell transplantation. On day +14, he develops fever, hypoxemia, and diffuse pulmonary infiltrates. Bronchoalveolar lavage shows hemorrhagic return with progressively bloodier aliquots. DAD is seen on transbronchial biopsy. Galactomannan, beta-D-glucan, and respiratory viral panel are negative. He is on tacrolimus with therapeutic levels. Which of the following findings would most strongly support a diagnosis of diffuse alveolar hemorrhage due to transplant-associated thrombotic microangiopathy rather than idiopathic pneumonia syndrome?", "options": ["Elevated serum lactate dehydrogenase with schistocytes on peripheral smear", "Presence of hemosiderin-laden macrophages in BAL fluid", "Concurrent acute kidney injury with proteinuria", "Elevated plasma-free hemoglobin with decreased haptoglobin", "Refractory thrombocytopenia despite platelet transfusions"], "answer": "E", "answer_index": 4, "explanation": "Transplant-associated thrombotic microangiopathy (TA-TMA) characteristically shows refractory thrombocytopenia that fails to increment appropriately with platelet transfusions due to ongoing platelet consumption in microthrombi. While elevated LDH, schistocytes, and decreased haptoglobin occur in both TA-TMA and other hemolytic processes, and AKI can occur in multiple post-transplant complications, the specific finding of platelet refractoriness distinguishes TA-TMA. Hemosiderin-laden macrophages simply confirm alveolar hemorrhage without indicating etiology. Idiopathic pneumonia syndrome does not cause platelet refractoriness.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question asks to distinguish Transplant-Associated Thrombotic Microangiopathy (TA-TMA) from Idiopathic Pneumonia Syndrome (IPS) in a post-HSCT patient with diffuse alveolar hemorrhage. The keyed answer (E) is 'Refractory thrombocytopenia.' However, Option A ('Elevated serum lactate dehydrogenase with schistocytes') represents the defining morphological hallmark of thrombotic microangiopathy (MAHA). Since IPS is a non-hemolytic lung injury, the presence of schistocytes and elevated LDH (Option A) is a definitive discriminator that strongly supports TA-TMA over IPS. The provided rationale rejects Option A on the grounds that it occurs in 'other hemolytic processes,' which is a logical fallacy: the question asks to distinguish TA-TMA from IPS, not from other hemolytic anemias. Furthermore, refractory thrombocytopenia (Option E) has a broader differential diagnosis in HSCT (e.g., alloimmunization, sepsis, graft failure) than the specific finding of microangiopathic hemolysis. Therefore, Option A is logically superior or at least equally defensible as the best answer. The item is miskeyed or has multiple correct answers based on standard diagnostic criteria.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question asks to distinguish Transplant-Associated Thrombotic Microangiopathy (TA-TMA) from Idiopathic Pneumonia Syndrome (IPS) in a post-HSCT patient with diffuse alveolar hemorrhage. The keyed answer (E) is 'Refractory thrombocytopenia.' However, Option A ('Elevated serum lactate dehydrogenase with schistocytes') represents the defining morphological hallmark of thrombotic microangiopathy (MAHA). Since IPS is a non-hemolytic lung injury, the presence of schistocytes and elevated LDH (Option A) is a definitive discriminator that strongly supports TA-TMA over IPS. The provided rationale rejects Option A on the grounds that it occurs in 'other hemolytic processes,' which is a logical fallacy: the question asks to distinguish TA-TMA from IPS, not from other hemolytic anemias. Furthermore, refractory thrombocytopenia (Option E) has a broader differential diagnosis in HSCT (e.g., alloimmunization, sepsis, graft failure) than the specific finding of microangiopathic hemolysis. Therefore, Option A is logically superior or at least equally defensible as the best answer. The item is miskeyed or has multiple correct answers based on standard diagnostic criteria.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-005", "question": "A 3-year-old girl presents with acute onset right-sided weakness and slurred speech. CT head is negative for hemorrhage. MRI reveals acute left middle cerebral artery territory infarction. Echocardiogram shows no structural abnormalities or vegetations. Hypercoagulability workup including protein C, protein S, antithrombin III, factor V Leiden, and prothrombin gene mutation are normal. Hemoglobin electrophoresis is normal. She had chickenpox 6 weeks ago. Cerebral angiography shows focal stenosis of the left distal internal carotid artery with a \"beaded\" appearance. Which of the following is the most appropriate long-term management?", "options": ["Lifelong warfarin anticoagulation", "Aspirin therapy for 2 years with serial vascular imaging", "Immediate surgical bypass of the stenotic segment", "High-dose intravenous immunoglobulin monthly", "Indefinite dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "B", "answer_index": 1, "explanation": "This presentation is classic for post-varicella arteriopathy (transient cerebral arteriopathy), which causes focal stenosis of large intracranial arteries following VZV infection. The condition is typically monophasic and self-limiting, with arterial changes stabilizing or improving over 6-24 months. Current guidelines recommend aspirin therapy for approximately 2 years with serial vascular imaging to monitor for progression or resolution. Anticoagulation is not superior to antiplatelet therapy and carries higher bleeding risk. Surgical bypass is not indicated for this typically self-resolving condition. IVIG has no established role in post-varicella arteriopathy.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic case of post-varicella arteriopathy (also known as transient cerebral arteriopathy of childhood), indicated by the acute ischemic stroke in a young child 6 weeks following a chickenpox infection, combined with focal stenosis of the distal internal carotid artery. This condition is typically monophasic and inflammatory. Current pediatric stroke guidelines (e.g., AHA/ASA) recommend antithrombotic therapy, typically aspirin, for secondary prevention. The duration is generally continued until arterial imaging stabilizes or normalizes, often requiring serial imaging over 1–2 years. Lifelong anticoagulation (Option A) is not indicated due to bleeding risk and the transient nature of the arteriopathy. Surgical bypass (Option C) is reserved for progressive Moyamoya or hemodynamic failure, not the initial management of TCA. IVIG (Option D) is not standard therapy. Indefinite DAPT (Option E) is not recommended. Therefore, Option B is the correct and best-supported answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic case of post-varicella arteriopathy (also known as transient cerebral arteriopathy of childhood), indicated by the acute ischemic stroke in a young child 6 weeks following a chickenpox infection, combined with focal stenosis of the distal internal carotid artery. This condition is typically monophasic and inflammatory. Current pediatric stroke guidelines (e.g., AHA/ASA) recommend antithrombotic therapy, typically aspirin, for secondary prevention. The duration is generally continued until arterial imaging stabilizes or normalizes, often requiring serial imaging over 1–2 years. Lifelong anticoagulation (Option A) is not indicated due to bleeding risk and the transient nature of the arteriopathy. Surgical bypass (Option C) is reserved for progressive Moyamoya or hemodynamic failure, not the initial management of TCA. IVIG (Option D) is not standard therapy. Indefinite DAPT (Option E) is not recommended. Therefore, Option B is the correct and best-supported answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-006", "question": "A 62-year-old man with small cell lung cancer develops progressive proximal weakness over 3 months. He has difficulty rising from chairs and climbing stairs. Examination reveals proximal muscle weakness (3/5), preserved reflexes, and no sensory deficits. CK is 4,200 U/L. EMG shows myopathic changes with fibrillation potentials. Muscle biopsy reveals necrotic and regenerating fibers with minimal inflammatory infiltrate. Testing for anti-Jo-1, anti-Mi-2, anti-SRP, and anti-MDA5 antibodies is negative. Which antibody is most likely to be positive in this patient?", "options": ["Anti-HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase)", "Anti-TIF1-gamma (transcription intermediary factor 1-gamma)", "Anti-NXP-2 (nuclear matrix protein 2)", "Anti-SAE (small ubiquitin-like modifier activating enzyme)", "Anti-HMGCR antibodies with concurrent anti-SRP positivity"], "answer": "B", "answer_index": 1, "explanation": "Anti-TIF1-gamma antibodies are strongly associated with malignancy-associated dermatomyositis/inflammatory myopathy, particularly in adults over 40 with underlying cancer. Small cell lung cancer is a known associated malignancy. The biopsy showing necrotizing features with minimal inflammation is consistent with immune-mediated necrotizing myopathy, which can occur with TIF1-gamma positivity in cancer-associated cases. Anti-HMGCR is associated with statin exposure and necrotizing myopathy but not specifically with malignancy. Anti-NXP-2 is associated with calcinosis and juvenile dermatomyositis. Anti-SAE is associated with dermatomyositis with systemic features but lower malignancy risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with Immune-Mediated Necrotizing Myopathy (IMNM), evidenced by severe proximal weakness, markedly elevated CK (4,200 U/L), and a muscle biopsy showing necrosis with minimal inflammatory infiltrate. The stem explicitly rules out Anti-SRP, leaving Anti-HMGCR (Option A) as the classic antibody associated with this specific pathological and clinical phenotype. While Anti-HMGCR is often statin-associated, it is also a recognized paraneoplastic antibody. The keyed answer, Anti-TIF1-gamma (Option B), is indeed strongly associated with malignancy (especially SCLC), but it is specific for Dermatomyositis. The patient lacks the pathognomonic skin rash of Dermatomyositis, and the biopsy lacks the characteristic perifascicular atrophy and inflammatory changes of Dermatomyositis. The item forces a choice between the antibody matching the cancer (TIF1-gamma) and the antibody matching the specific myopathy phenotype (HMGCR). Since the biopsy findings are the gold standard for classifying the myopathy as IMNM (not Dermatomyositis), Option A is the medically correct answer. The explanation incorrectly states HMGCR is not associated with malignancy and conflates IMNM pathology with TIF1-gamma Dermatomyositis.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with Immune-Mediated Necrotizing Myopathy (IMNM), evidenced by severe proximal weakness, markedly elevated CK (4,200 U/L), and a muscle biopsy showing necrosis with minimal inflammatory infiltrate. The stem explicitly rules out Anti-SRP, leaving Anti-HMGCR (Option A) as the classic antibody associated with this specific pathological and clinical phenotype. While Anti-HMGCR is often statin-associated, it is also a recognized paraneoplastic antibody. The keyed answer, Anti-TIF1-gamma (Option B), is indeed strongly associated with malignancy (especially SCLC), but it is specific for Dermatomyositis. The patient lacks the pathognomonic skin rash of Dermatomyositis, and the biopsy lacks the characteristic perifascicular atrophy and inflammatory changes of Dermatomyositis. The item forces a choice between the antibody matching the cancer (TIF1-gamma) and the antibody matching the specific myopathy phenotype (HMGCR). Since the biopsy findings are the gold standard for classifying the myopathy as IMNM (not Dermatomyositis), Option A is the medically correct answer. The explanation incorrectly states HMGCR is not associated with malignancy and conflates IMNM pathology with TIF1-gamma Dermatomyositis.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-007", "question": "A 28-year-old woman at 32 weeks gestation presents with severe headache, visual changes, and right upper quadrant pain. Blood pressure is 178/112 mmHg. Laboratory studies show platelets 62,000/μL, AST 342 U/L, ALT 298 U/L, LDH 890 U/L, creatinine 1.8 mg/dL, and peripheral smear with schistocytes. Urinalysis shows 3+ protein. She receives magnesium sulfate and labetalol. Despite delivery 6 hours later, her platelet count drops to 28,000/μL and creatinine rises to 3.2 mg/dL over the next 48 hours. ADAMTS13 activity returns at 68%. Which of the following is the most appropriate next step in management?", "options": ["Initiate therapeutic plasma exchange", "Administer eculizumab", "Begin rituximab infusion", "Transfuse platelets to maintain count above 50,000/μL", "Continue supportive care with expectant management"], "answer": "B", "answer_index": 1, "explanation": "This patient has pregnancy-associated atypical hemolytic uremic syndrome (aHUS), evidenced by persistent/worsening microangiopathic hemolytic anemia and renal failure after delivery with ADAMTS13 activity >10% (ruling out TTP). Complement-mediated aHUS can be triggered by pregnancy and does not resolve with delivery alone. Eculizumab, a C5 complement inhibitor, is the treatment of choice for aHUS. Plasma exchange is first-line for TTP (ADAMTS13 <10%) but less effective in aHUS. Rituximab targets B cells and is used for autoimmune TTP. Platelet transfusion is relatively contraindicated in TMA. Expectant management risks progressive renal failure.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient initially presenting with HELLP syndrome who deteriorates 48 hours postpartum with worsening renal failure (Cr 3.2 mg/dL) and thrombocytopenia. The key discriminator is the ADAMTS13 activity of 68%, which effectively rules out Thrombotic Thrombocytopenic Purpura (TTP, which requires <10% activity). While HELLP syndrome typically improves after delivery, the worsening clinical picture and severe renal involvement strongly suggest an alternative Thrombotic Microangiopathy (TMA), specifically atypical Hemolytic Uremic Syndrome (aHUS), which is complement-mediated and often pregnancy-triggered. Eculizumab (C5 inhibitor) is the specific, first-line treatment for aHUS. Plasma exchange (Option A) is the treatment for TTP and is less effective for aHUS; since TTP is ruled out by the labs provided, Eculizumab is the superior choice. Platelet transfusion is generally contraindicated in TMAs, and expectant management is unsafe given the organ failure. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient initially presenting with HELLP syndrome who deteriorates 48 hours postpartum with worsening renal failure (Cr 3.2 mg/dL) and thrombocytopenia. The key discriminator is the ADAMTS13 activity of 68%, which effectively rules out Thrombotic Thrombocytopenic Purpura (TTP, which requires <10% activity). While HELLP syndrome typically improves after delivery, the worsening clinical picture and severe renal involvement strongly suggest an alternative Thrombotic Microangiopathy (TMA), specifically atypical Hemolytic Uremic Syndrome (aHUS), which is complement-mediated and often pregnancy-triggered. Eculizumab (C5 inhibitor) is the specific, first-line treatment for aHUS. Plasma exchange (Option A) is the treatment for TTP and is less effective for aHUS; since TTP is ruled out by the labs provided, Eculizumab is the superior choice. Platelet transfusion is generally contraindicated in TMAs, and expectant management is unsafe given the organ failure. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-008", "question": "A 14-year-old boy with no significant medical history presents after a witnessed generalized tonic-clonic seizure lasting 2 minutes with spontaneous termination. He reports a 3-month history of early morning myoclonic jerks causing him to drop objects, which he attributed to clumsiness. EEG shows 4-6 Hz generalized polyspike-and-wave discharges with photosensitivity. MRI brain is normal. His father had similar episodes as a teenager that resolved. Which of the following medications should be specifically avoided in this patient?", "options": ["Levetiracetam", "Valproic acid", "Lamotrigine", "Carbamazepine", "Topiramate"], "answer": "D", "answer_index": 3, "explanation": "This patient has juvenile myoclonic epilepsy (JME), characterized by myoclonic jerks (especially morning), generalized tonic-clonic seizures, photosensitivity, and generalized polyspike-and-wave on EEG. Carbamazepine and other sodium channel blockers (phenytoin, oxcarbazepine) can paradoxically worsen myoclonic and absence seizures in genetic generalized epilepsies like JME by enhancing thalamocortical synchronization. Valproic acid is highly effective but avoided in women of childbearing potential due to teratogenicity. Levetiracetam and lamotrigine are appropriate alternatives. Topiramate has broad-spectrum efficacy including in JME.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic case of Juvenile Myoclonic Epilepsy (JME), evidenced by the patient's age, morning myoclonic jerks ('dropsies'), generalized tonic-clonic seizures, and characteristic EEG findings (generalized polyspike-and-wave). The question asks to identify the medication that should be specifically avoided. In genetic generalized epilepsies like JME, narrow-spectrum sodium channel blockers—specifically Carbamazepine (Option D), phenytoin, and oxcarbazepine—are contraindicated because they can paradoxically aggravate myoclonic and absence seizures. Valproic acid (Option B) is the standard first-line treatment for JME in males. Levetiracetam (Option A) and Topiramate (Option E) are effective broad-spectrum adjunctive or alternative therapies. While Lamotrigine (Option C) has a mixed record regarding myoclonus, Carbamazepine is the definitive and most commonly tested medication to avoid in this context due to the mechanism of seizure worsening. The item is logically sound, medically accurate, and relies on a well-established teaching point regarding seizure classification and drug selection.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic case of Juvenile Myoclonic Epilepsy (JME), evidenced by the patient's age, morning myoclonic jerks ('dropsies'), generalized tonic-clonic seizures, and characteristic EEG findings (generalized polyspike-and-wave). The question asks to identify the medication that should be specifically avoided. In genetic generalized epilepsies like JME, narrow-spectrum sodium channel blockers—specifically Carbamazepine (Option D), phenytoin, and oxcarbazepine—are contraindicated because they can paradoxically aggravate myoclonic and absence seizures. Valproic acid (Option B) is the standard first-line treatment for JME in males. Levetiracetam (Option A) and Topiramate (Option E) are effective broad-spectrum adjunctive or alternative therapies. While Lamotrigine (Option C) has a mixed record regarding myoclonus, Carbamazepine is the definitive and most commonly tested medication to avoid in this context due to the mechanism of seizure worsening. The item is logically sound, medically accurate, and relies on a well-established teaching point regarding seizure classification and drug selection.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-009", "question": "A 55-year-old man is admitted to the ICU with septic shock secondary to necrotizing pancreatitis. Despite adequate fluid resuscitation and norepinephrine at 0.5 mcg/kg/min, his MAP remains 58 mmHg. Vasopressin 0.04 units/min is added. Central venous oxygen saturation is 58%, lactate is 6.2 mmol/L, and cardiac index by thermodilution is 2.0 L/min/m². Echocardiogram shows hyperdynamic left ventricle with LVEF 70% and small, underfilled chambers. Which of the following is the most appropriate next intervention?", "options": ["Add dobutamine for inotropic support", "Administer additional crystalloid bolus", "Initiate phenylephrine infusion", "Add epinephrine as third vasopressor", "Begin hydrocortisone 50 mg IV every 6 hours"], "answer": "B", "answer_index": 1, "explanation": "Despite initial resuscitation, the echocardiographic findings of hyperdynamic LV with small, underfilled chambers indicate persistent hypovolemia. The low ScvO2 (58%) and elevated lactate suggest inadequate oxygen delivery. In the setting of distributive shock with evidence of preload deficiency, additional volume resuscitation is indicated before adding further vasopressors. Dobutamine would be inappropriate given the already hyperdynamic state. Phenylephrine causes pure vasoconstriction without inotropy and may worsen cardiac output. Epinephrine could be considered after optimizing preload. Hydrocortisone is indicated for refractory shock but addressing hypovolemia takes priority.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette presents a patient in septic shock with refractory hypotension despite high-dose norepinephrine and vasopressin. While the stem mentions 'adequate fluid resuscitation' historically, the objective data—specifically the echocardiogram showing a hyperdynamic left ventricle with small, underfilled chambers—provides definitive evidence of persistent hypovolemia (preload dependence). The low cardiac index (2.0 L/min/m²) and low ScvO2 (58%) are secondary to low stroke volume from inadequate preload. In this specific physiological context, the 'best' next step is to correct the volume deficit (Option B). Adding inotropes (Option A) to an empty, hyperdynamic heart is contraindicated (risk of LVOT obstruction). While hydrocortisone (Option E) is indicated for septic shock refractory to vasopressors, the specific hemodynamic profile (underfilled chambers) demands volume expansion as the immediate priority to restore perfusion. The question relies on the standard board-exam principle that objective hemodynamic data (Echo) overrides protocol-based history ('adequate fluid'). The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette presents a patient in septic shock with refractory hypotension despite high-dose norepinephrine and vasopressin. While the stem mentions 'adequate fluid resuscitation' historically, the objective data—specifically the echocardiogram showing a hyperdynamic left ventricle with small, underfilled chambers—provides definitive evidence of persistent hypovolemia (preload dependence). The low cardiac index (2.0 L/min/m²) and low ScvO2 (58%) are secondary to low stroke volume from inadequate preload. In this specific physiological context, the 'best' next step is to correct the volume deficit (Option B). Adding inotropes (Option A) to an empty, hyperdynamic heart is contraindicated (risk of LVOT obstruction). While hydrocortisone (Option E) is indicated for septic shock refractory to vasopressors, the specific hemodynamic profile (underfilled chambers) demands volume expansion as the immediate priority to restore perfusion. The question relies on the standard board-exam principle that objective hemodynamic data (Echo) overrides protocol-based history ('adequate fluid'). The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-010", "question": "A 7-year-old boy presents with 2 weeks of progressive gait instability and tremor. Examination reveals opsoclonus (chaotic, multidirectional saccadic eye movements), myoclonus, and truncal ataxia. MRI brain and spine are normal. CSF shows mild lymphocytic pleocytosis. CT chest/abdomen/pelvis reveals a paraspinal mass. Urine catecholamines are elevated. Tumor resection is planned. Which of the following additional findings would indicate the WORST long-term neurodevelopmental prognosis despite tumor treatment?", "options": ["Presence of anti-Hu antibodies in serum", "CSF oligoclonal bands with elevated IgG index", "Age less than 3 years at symptom onset", "Tumor histology showing neuroblastoma with MYCN amplification", "Delayed initiation of immunotherapy beyond 4 weeks from diagnosis"], "answer": "C", "answer_index": 2, "explanation": "Opsoclonus-myoclonus-ataxia syndrome (OMS) associated with neuroblastoma has variable neurodevelopmental outcomes. Younger age at onset (particularly <3 years) is paradoxically associated with worse long-term cognitive and behavioral outcomes, likely due to the impact of neuroinflammation on the developing brain during critical periods. While MYCN amplification indicates aggressive tumor biology, it does not correlate with neurological outcomes. Anti-Hu antibodies are rare in pediatric OMS. CSF inflammatory markers and treatment delays affect outcomes but age remains the strongest predictor of neurodevelopmental sequelae.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: C (Contradiction). Verdict: No defensible answer due to logical impossibility. The vignette describes a specific patient: a 7-year-old boy with symptoms starting 2 weeks ago. The question asks for an 'additional finding' in this patient that would indicate the worst prognosis. The keyed answer (C) is 'Age less than 3 years at symptom onset.' It is logically impossible for a 7-year-old with recent onset to meet this criterion. The option contradicts the established facts of the vignette. While the underlying medical teaching point is correct (younger age at onset in OMS is associated with worse neurocognitive outcomes), the item construction fails because the correct answer is excluded by the stem's demographics. Option E (delayed treatment) is a plausible negative prognostic factor that is logically possible, but likely not the intended key. Minimal fix: Remove the specific age from the vignette (e.g., 'A child presents...') or rephrase the question as a general knowledge item about OMS prognosis, removing the specific patient context.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: C (Contradiction). Verdict: No defensible answer due to logical impossibility. The vignette describes a specific patient: a 7-year-old boy with symptoms starting 2 weeks ago. The question asks for an 'additional finding' in this patient that would indicate the worst prognosis. The keyed answer (C) is 'Age less than 3 years at symptom onset.' It is logically impossible for a 7-year-old with recent onset to meet this criterion. The option contradicts the established facts of the vignette. While the underlying medical teaching point is correct (younger age at onset in OMS is associated with worse neurocognitive outcomes), the item construction fails because the correct answer is excluded by the stem's demographics. Option E (delayed treatment) is a plausible negative prognostic factor that is logically possible, but likely not the intended key. Minimal fix: Remove the specific age from the vignette (e.g., 'A child presents...') or rephrase the question as a general knowledge item about OMS prognosis, removing the specific patient context.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 3}]